Board Appointment

RNS Number : 1282E

Futura Medical PLC

24 September 2008

 



For immediate release

24 September 2008

Futura Medical plc

('Futura' or 'the Group' or 'the Company')

Appointment of Finance Director

Futura Medical plc (AIM: FUM), the pharmaceutical group that develops innovative products for consumer healthcare, is pleased to announce that Derek Martin, who joined Futura as Financial Controller in April 2007, has been appointed to the Board of Futura as Finance Director with immediate effect. 

Derek Adrian Martin, age 47, is a chartered accountant with a breadth of experience gained across a number of sectors, including technology and retail, at private and publicly quoted companies of varying sizes.

Prior to joining Futura, Mr Martin was a financial controller at Thales.  Between 2005 and 2007 he was financial controller at Links of London Limited, the jewellery chain, before its disposal to Folli Follie, and between 2001 and 2005 he was financial controller at Entuity Limited, a US software company. Mr Martin gained AIM experience in the role of financial controller at World Telecom plc, between 1996 and 2001, prior to the company's sale to Torc Telecom Limited.

James Barder, Futura's Chief Executive, said: 'I am delighted to welcome Derek to the role of Finance Director and to Futura's Board. He has worked at Futura in the role of Financial Controller since April 2007 and has proved himself to be a highly competent finance executive. I look forward to his contribution to Futura's Board.'

There are no further disclosures to be made in accordance with Schedule 2 (g) of the AIM rules.

For any further information please contact:

Futura Medical plc
James Barder, Chief Executive	Tel: [phone]
mail to: [e-mail]	www.futuramedical.co.uk
Canaccord Adams
Ryan Gaffney / Adria Da Breo Richards	Tel: [phone]
For media enquiries please contact:
Buchanan Communications
Mark Court / Rebecca Skye Dietrich	Tel: [phone]

Notes to Editors

Futura Medical plc

Futura Medical is a pharmaceutical group that develops innovative products for consumer healthcare. The Company is developing a portfolio of products and its strategy is to license their manufacture and distribution to major pharmaceutical and healthcare groups.

Futura is based in Guildford, Surrey, and its shares trade on the AIM market of the London Stock Exchange.

www.futuramedical.co.uk

 

END

 

 

BOAQXLFLVKBBBBF